Literature DB >> 18782690

Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.

Kanitpong Phabphal1, Kitti Limapichat, Ponchi Sathirapanya, Suwanna Setthawatcharawanich, Rattana Leelawattana, Natawan Thammakumpee, Atchara Thamaprasit, Alan Geater.   

Abstract

The objective of this study was to investigate bone mineral density (BMD) in Thai epileptics who had been receiving long-term, antiepileptic drugs. Subjects were epileptic patients aged 15 to 50 years who had been taking antiepileptic drugs for longer than six months. All were free of disease and none was taking any medication that might interfere with bone metabolism other than antiepileptic drugs. BMD at the left femoral neck and spine was measured with dual energy X-ray absorptiometry. Demographic data, basic laboratory studies and history of clinical epilepsy were obtained. One hundred and thirty patients (63 males and 67 females) were included. Mean age (+ SD) was 31.9 +/- 9.7 year. There were 79 patients receiving monotherapy and 51 patients receiving polytherapy. All patients had normal serum calcium. Thirteen patients had slightly low serum phosphate levels. The BMD at the femoral neck had a mean Z-score - 0.15 +/- 1.17 and the mean Z-score at the lumbar spine was - 0.56 +/- 1.03. Thirty one patients had osteopenia at the spine and 30 patients at the femoral neck. Three patients had osteoporosis of the spine and 1 patient of the femoral neck. There was found to be no significant correlation between age, sex, body mass index, duration of treatment and type of antiepileptic drug with bone mineral density at the femur and spine. The mean BMD of long-term antiepileptic users was lower than that of the sex and age-adjusted mean.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782690     DOI: 10.1684/epd.2008.0208

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  3 in total

Review 1.  Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.

Authors:  Peter Vestergaard
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

2.  Bone status in patients with epilepsy: relationship to markers of bone remodeling.

Authors:  Sherifa A Hamed; Ehab M M Moussa; Ahmad H Youssef; Mohammed A Abd ElHameed; Eman NasrEldin
Journal:  Front Neurol       Date:  2014-08-04       Impact factor: 4.003

3.  Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.

Authors:  Chien-Ming Lin; Hueng-Chuen Fan; Tsu-Yi Chao; Der-Ming Chu; Chi-Chieh Lai; Chih-Chien Wang; Shyi-Jou Chen
Journal:  BMC Pediatr       Date:  2016-05-03       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.